Overview

Study of Elobixibat (A3309) in Patients With Chronic Idiopathic Constipation

Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this trial is to determine the efficacy and safety of A3309 administered to patients with chronic idiopathic constipation.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Albireo
Criteria
Inclusion Criteria:

- Patient meets protocol specified criteria for constipation

- Patient has successfully completed study requirements with no clinically relevant
findings for physical exam, ECG, laboratory tests and colonoscopy as applicable

Exclusion Criteria:

- Medical history or medical condition that would not make the patient a good candidate
for the study or limit the patient´s ability to complete the study

- Patient reports loose stools

- Patient has IBS with pain/discomfort as predominant symptom

- Patient needs medications prohibited as specified in the protocol